Related Experiment Video
Updated: Jul 23, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
Cardiac stem cell therapy for myocardial regeneration. A clinical perspective
B Dawn1, E K Zuba-Surma, A Abdel-Latif
1Institute of Molecular Cardiology, Division of Cardiology, University of Louisville, Louisville, KY 40292, USA. buddha@louisville.edu
Insights
Adult stem cells show promise for regenerating heart tissue after myocardial infarction. Clinical trials indicate cell therapy can improve cardiac function and structure, offering hope for heart failure patients.
Area of Science:
- Cardiology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Myocardial infarction leads to cardiomyocyte loss, scar formation, and heart failure, with limited regenerative capacity from current treatments.
- Heart failure remains a global health issue due to the inability to regenerate dead myocardium.
- Recent research in animal models suggests adult primitive cells can regenerate cardiac tissue and vasculature, improving heart function.
Purpose of the Study:
- To review the feasibility of cardiac repair in humans using adult stem/progenitor cells.
- To discuss the therapeutic potential of cardiac stem cells for myocardial regeneration.
Main Methods:
- Review of recent studies in animal models of myocardial infarction and heart failure.
- Analysis of small clinical trials involving cell therapy for myocardial infarction and ischemic cardiomyopathy.
- Examination of the discovery and characteristics of adult cardiac stem cells.
Main Results:
- Cell therapy has shown beneficial effects in human clinical trials, including infarct size reduction and improved ejection fraction, myocardial perfusion, and wall motion.
- Various adult primitive cell subsets have demonstrated the ability to regenerate cardiomyocytes and cardiac vasculature.
- Adult cardiac stem cells offer potential for endogenous myocardial regeneration.
Conclusions:
- Adult stem/progenitor cells hold promise for cardiac repair and myocardial regeneration in humans.
- Further research is needed to determine the optimal cell populations and their therapeutic utility.
- Cardiac stem cells present a novel avenue for treating heart failure post-myocardial infarction.
Abstract:
Myocardial infarction and other pathologic conditions of the heart result in loss of cardiomyocytes, scar formation, ventricular remodeling, and eventually heart failure. Since pharmacologic and interventional strategies fail to regenerate dead myocardium, heart failure continues to be a major health problem worldwide. Recent studies in animal models of myocardial infarction and heart failure have demonstrated that various subsets of adult primitive cells can regenerate functional cardiomyocytes and cardiac vasculature with improvement in cardiac structure and function. Small clinical trials of cell therapy in patients with myocardial infarction and ischemic cardiomyopathy have recapitulated these beneficial effects in humans with infarct size reduction and improvement in ejection fraction, myocardial perfusion, and wall motion. Several phenotypically distinct cell populations have been utilized for cardiac regeneration, and the relative merits of one cell over another remain to be determined. The recent discovery of adult cardiac stem cells has sparked intense hope for myocardial regeneration with cells that are from the heart itself and are thereby inherently programmed to reconstitute cardiac tissue. The purpose of this review is to summarize the evidence regarding the feasibility of cardiac repair in humans via adult stem/progenitor cells, and to discuss the potential utility of cardiac stem cells for therapeutic myocardial regeneration.
Related Concept Videos
Adult Stem Cells
Clinical Applications of Epidermal Stem Cells
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

